No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 20.760
- +0.290+1.42%
Trading Jul 23 10:33 ET
759.33MMarket Cap-14317P/E (TTM)
20.760High19.664Low10.63KVolume20.080Open20.470Pre Close214.14KTurnover0.12%Turnover RatioLossP/E (Static)36.58MShares28.08052wk High-19.15P/B190.99MFloat Cap18.00052wk Low--Dividend TTM9.20MShs Float28.080Historical High--Div YieldTTM5.36%Amplitude18.000Historical Low20.143Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Rapport Therapeutics(RAPP.US) Director Buys US$1.08 Million in Common Stock
Stifel Starts Rapport at Buy, Cites Lead Drug Candidate RAP-219
TD Cowen Initiates Rapport Therapeutics(RAPP.US) With Buy Rating
Rapport Therapeutics Analyst Ratings
Express News | Rapport Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating
Stifel Initiates Rapport Therapeutics(RAPP.US) With Buy Rating, Announces Target Price $35
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
